Category: Providers

Major North Carolina Health System Sues Aetna, Humana for Alleged 340B Underpayment

June 17, 2025 William Newton, Associate Editor/Senior Writer Views

UNC Health recently sued Aetna and Humana in a federal district court for allegedly underpaying hospitals for 340B drugs.

A major North Carolina health system has sued insurers Aetna Health and Humana for allegedly underpaying for 340B drugs purchased [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Vermont, Oregon Enact 340B Contract Pharmacy Access Laws; Vermont Measure Includes Controversial Hospital Price Caps

June 12, 2025 William Newton, Associate Editor/Senior Writer Views

Vermont Gov. Phil Scott (R) and Oregon Gov. Tina Kotek (D) each signed 340B legislation in their states on June 11.

Vermont and Oregon yesterday became the latest states to enact 340B contract pharmacy access laws, with Vermont’s new statute also [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Federal Appellate Court Fast-Tracks Drugmakers’ Appeal of 340B Rebate Ruling

June 12, 2025 William Newton, Associate Editor/Senior Writer Views

A federal appellate court in Washington, D.C. will hear two drugmakers' appeal of a lower courts 340B rebate ruling on an expedited schedule.

A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS Offers New Details on Medicare Drug Price Negotiations, 340B Advocates Raise Concerns About Impact on Program

June 12, 2025 Shannon Young, Associate Editor/Senior Writer Views

340B stakeholders raised concerns about May 12 draft guidance on the IRA Medicare Drug Price Negotiation Program's “manufacturer effectuation of the maximum fair price in 2026, 2027 and 2028,” among other things.

The Centers for Medicare and Medicaid Services (CMS) released new details this week to help stakeholders navigate the Inflation Reduction [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Leading 340B and Pharmacy Solutions Firm Maxor Rebrands as ‘VytlOne’

June 12, 2025 William Newton, Associate Editor/Senior Writer Views

Kim Tzoumakas, CEO of VytlOne (formerly Maxor), said the company's rebrand "exemplifies our unique position as a full-service pharmacy management partner."

Maxor, a leading integrated pharmacy services and 340B solutions provider first established nearly 100 years ago in a small Texas [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

How Oklahoma Lawmakers Defied Their Governor and Fought Dark Money to Enact a 340B Contract Pharmacy Access Law

June 10, 2025 William Newton, Associate Editor/Senior Writer Views

Oklahoma state lawmakers overrode their governor's veto to enact a 340B contract pharmacy access law despite strong opposition from dark money groups and conservative influencers.

In the final hour of Oklahoma’s 2025 legislative session, as the clock neared 11 p.m. on May 29, state legislators [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug-Industry Funded Study Finds Utilization Drives 340B Program Growth, Not Rising Drug Prices

June 10, 2025 Bella Czajkowski, National Correspondent Views

A recent drug-industry funded study in Health Affairs Scholar found that increased utilization, rather than rising drug prices, drives 340B program growth.

A recent drug-industry-funded study attributes the 340B program’s recent growth to increased utilization—not rising drug prices. The May 21 study, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

In Emergency Motion, Novartis and BMS Urge Appellate Court to Fast-Track Their Appeals of 340B Rebate Ruling

June 5, 2025 William Newton, Associate Editor/Senior Writer Views

Novartis and BMS filed an emergency motion with the federal appeals court in Washington, D.C. to appeal a recent ruling on drugmaker 340B rebates.

Novartis and Bristol Myers Squibb (BMS) are asking a federal appeals court to expedite their challenge to a recent ruling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Indiana’s New Budget Law Sparks Alarm Over Last-Minute Provisions Targeting 340B Medicaid Reimbursement

June 5, 2025 William Newton, Associate Editor/Senior Writer Views

Indiana's newly enacted budget law includes late-added provisions that could affect 340B providers serving Medicaid managed care beneficiaries.

A late amendment to Indiana’s newly enacted budget law grants the state broad authority to restrict how 340B drugs are [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Oregon Sends 340B Contract Pharmacy Access Bill to Governor; Illinois Falls Short but Advances PBM Reform

June 3, 2025 William Newton, Associate Editor/Senior Writer Views

Both chambers of the Oregon legislature have passed a 340B contract pharmacy access bill, sending it to the state governor.

The Oregon Legislature yesterday sent a 340B contract pharmacy access bill to the state’s governor, shortly after Illinois lawmakers failed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live